Literature DB >> 30557660

A multiomic approach to characterize the temporal sequence in Alzheimer's disease-related pathology.

Mikael Marttinen1, Jussi Paananen1, Antonio Neme1, Vikram Mitra2, Mari Takalo1, Teemu Natunen1, Kaisa M A Paldanius1, Petra Mäkinen1, Michael Bremang2, Mitja I Kurki3, Tuomas Rauramaa4, Ville Leinonen5, Hilkka Soininen6, Annakaisa Haapasalo7, Ian Pike2, Mikko Hiltunen8.   

Abstract

No single-omic approach completely elucidates the multitude of alterations taking place in Alzheimer's disease (AD). Here, we coupled transcriptomic and phosphoproteomic approaches to determine the temporal sequence of changes in mRNA, protein, and phosphopeptide expression levels from human temporal cortical samples, with varying degree of AD-related pathology. This approach highlighted fluctuation in synaptic and mitochondrial function as the earliest pathological events in brain samples with AD-related pathology. Subsequently, increased expression of inflammation and extracellular matrix-associated gene products was observed. Interaction network assembly for the associated gene products, emphasized the complex interplay between these processes and the role of addressing post-translational modifications in the identification of key regulators. Additionally, we evaluate the use of decision trees and random forests in identifying potential biomarkers differentiating individuals with different degree of AD-related pathology. This multiomic and temporal sequence-based approach provides a better understanding of the sequence of events leading to AD.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Human brain; Phosphoproteomics; Systems biology; Transcriptomics

Mesh:

Year:  2018        PMID: 30557660     DOI: 10.1016/j.nbd.2018.12.009

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  16 in total

Review 1.  Molecular Signatures of the Aging Brain: Finding the Links Between Genes and Phenotypes.

Authors:  Giuseppe Lupo; Silvana Gaetani; Emanuele Cacci; Stefano Biagioni; Rodolfo Negri
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 2.  Epileptic Mechanisms Shared by Alzheimer's Disease: Viewed via the Unique Lens of Genetic Epilepsy.

Authors:  Jing-Qiong Kang
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

Review 3.  Transcriptional Networks of Microglia in Alzheimer's Disease and Insights into Pathogenesis.

Authors:  Gabriel Chew; Enrico Petretto
Journal:  Genes (Basel)       Date:  2019-10-12       Impact factor: 4.096

Review 4.  Contributions from the 2019 Literature on Bioinformatics and Translational Informatics.

Authors:  Malika Smaïl-Tabbone; Bastien Rance
Journal:  Yearb Med Inform       Date:  2020-08-21

5.  MECP2 Increases the Pro-Inflammatory Response of Microglial Cells and Phosphorylation at Serine 423 Regulates Neuronal Gene Expression upon Neuroinflammation.

Authors:  Rebekka Wittrahm; Mari Takalo; Mikael Marttinen; Teemu Kuulasmaa; Petra Mäkinen; Susanna Kemppainen; Henna Martiskainen; Tuomas Rauramaa; Ian Pike; Ville Leinonen; Teemu Natunen; Annakaisa Haapasalo; Mikko Hiltunen
Journal:  Cells       Date:  2021-04-09       Impact factor: 6.600

6.  Phosphoproteomics identifies microglial Siglec-F inflammatory response during neurodegeneration.

Authors:  Nader Morshed; William T Ralvenius; Alexi Nott; L Ashley Watson; Felicia H Rodriguez; Leyla A Akay; Brian A Joughin; Ping-Chieh Pao; Jay Penney; Lauren LaRocque; Diego Mastroeni; Li-Huei Tsai; Forest M White
Journal:  Mol Syst Biol       Date:  2020-12       Impact factor: 11.429

7.  A novel phosphoproteomic landscape evoked in response to type I interferon in the brain and in glial cells.

Authors:  Barney Viengkhou; Melanie Y White; Stuart J Cordwell; Iain L Campbell; Markus J Hofer
Journal:  J Neuroinflammation       Date:  2021-10-16       Impact factor: 8.322

8.  Pathogenesis of sporadic Alzheimer's disease by deficiency of NMDA receptor subunit GluN3A.

Authors:  Weiwei Zhong; Anika Wu; Ken Berglund; Xiaohuan Gu; Michael Qize Jiang; Jay Talati; Jingjie Zhao; Ling Wei; Shan Ping Yu
Journal:  Alzheimers Dement       Date:  2021-06-20       Impact factor: 21.566

9.  Multi-omics signature of brain amyloid deposition in asymptomatic individuals at-risk for Alzheimer's disease: The INSIGHT-preAD study.

Authors:  Laura Xicota; Farid Ichou; François-Xavier Lejeune; Benoit Colsch; Arthur Tenenhaus; Inka Leroy; Gaëlle Fontaine; Marie Lhomme; Hugo Bertin; Marie-Odile Habert; Stéphane Epelbaum; Bruno Dubois; Fanny Mochel; Marie-Claude Potier
Journal:  EBioMedicine       Date:  2019-09-03       Impact factor: 8.143

Review 10.  Apolipoprotein E4 and meningeal lymphatics in Alzheimer disease: a conceptual framework.

Authors:  Alexios-Fotios A Mentis; Efthimios Dardiotis; George P Chrousos
Journal:  Mol Psychiatry       Date:  2020-04-30       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.